Scholarlink

Background <p>Elderly patients are increasingly being offered allogeneic hematopoietic cell transplantation (HCT), and several strategies have been developed to meet their needs. The objective of the current study was to report the feasibility of a reduced-intensity busulfan/fludarabine conditioning regimen with total marrow irradiation in older patients.</p> Methods <p>This single-center study included 28 patients aged 60–77 years with a median follow-up of 34 months. </p> Results <p>Overall survival at 2 years was 46%, relapse rate was 30%, and non-relapse mortality was 23%, yielding a progression-free survival of 46%. Rates of grades II-IV acute GVHD, III-IV acute GVHD, and chronic GVHD were 47%, 8%, and 19%, respectively. Only one patient did not achieve neutrophil engraftment. Three patients experienced sinusoidal obstruction syndrome, and all recovered. Causes of death included disease progression (<i>n</i> = 10), infection (<i>n</i> = 5, including one COVID-19 case), and acute myocardial infarction (<i>n</i> = 1).</p> Conclusion <p>Our results demonstrate the feasibility of an intensified, total marrow irradiation-based conditioning regimen in an elderly cohort, primarily comprising transplants from alternative donors for high-risk diseases. Non-relapse mortality was very low, given the patients’ profile, and compares favorably with others reports reduced-intensity regimen with total body irradiation in older patients. Future studies should compare it to the standard reduced-intensity and non-myeloablative regimens.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Total marrow irradiation-based, reduced-intensity conditioning regimen for elderly patients undergoing hematopoietic cell transplantation for hematological malignancies

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月30日

查看全文
  • Leonardo Javier Arcuri,
  • Mariana Kerbauy,
  • Lucila Kerbauy,
  • Juliana Dall’Agnol da Rocha,
  • Carolina Perrone,
  • Tarcila Datoguia,
  • Jade Zezzi Martins do Nascimento,
  • Morgani Rodrigues,
  • Ana Carolina Pires de Rezende,
  • Eduardo Weltman,
  • Roberto Sakuraba,
  • Andreza Alice Feitosa Ribeiro,
  • Marcos de Lima,
  • Nelson Hamerschlak

摘要

Background

Elderly patients are increasingly being offered allogeneic hematopoietic cell transplantation (HCT), and several strategies have been developed to meet their needs. The objective of the current study was to report the feasibility of a reduced-intensity busulfan/fludarabine conditioning regimen with total marrow irradiation in older patients.

Methods

This single-center study included 28 patients aged 60–77 years with a median follow-up of 34 months.

Results

Overall survival at 2 years was 46%, relapse rate was 30%, and non-relapse mortality was 23%, yielding a progression-free survival of 46%. Rates of grades II-IV acute GVHD, III-IV acute GVHD, and chronic GVHD were 47%, 8%, and 19%, respectively. Only one patient did not achieve neutrophil engraftment. Three patients experienced sinusoidal obstruction syndrome, and all recovered. Causes of death included disease progression (n = 10), infection (n = 5, including one COVID-19 case), and acute myocardial infarction (n = 1).

Conclusion

Our results demonstrate the feasibility of an intensified, total marrow irradiation-based conditioning regimen in an elderly cohort, primarily comprising transplants from alternative donors for high-risk diseases. Non-relapse mortality was very low, given the patients’ profile, and compares favorably with others reports reduced-intensity regimen with total body irradiation in older patients. Future studies should compare it to the standard reduced-intensity and non-myeloablative regimens.